Airway inflammation, exhaled nitric oxide, and severity of asthma in patients with western red cedar asthma

被引:29
作者
Chan-Yeung, M [1 ]
Obata, H [1 ]
Dittrick, M [1 ]
Chan, H [1 ]
Abboud, R [1 ]
机构
[1] Univ British Columbia, Vancouver Gen Hosp, Div Resp, Vancouver, BC V5Z 3J5, Canada
关键词
D O I
10.1164/ajrccm.159.5.9807007
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Examination of induced sputum and measurement of exhaled NO have been advocated as noninvasive methods of assessing the degree of airway inflammation. In this study, we performed follow-up evaluation on 71 subjects with asthma caused by exposure to Western red cedar; 50 subjects had left exposure, whereas the rest continued to work in the same job. Spirometry, methacholine challenge tests, exhaled nitric oxide, and sputum induction were carried out. Of the 50 subjects who left exposure, 12 had no respiratory impairment according to the American Throacic Society guidelines for assessing respiratory impairment in patients with asthma, 17 belonged to Class 1, 12 to Class 2, five to Class 3, and four to Class 4. The percentage of eosinophils in induced sputum showed a significant inverse relationship with FEV, (r = -0.46, p < 0.001), and a significant positive correlation with levels of exhaled NO (r = 0.42, p < 0.001) and with the class of respiratory impairment: (r = 0.52, p < 0.001). Mean percent eosinophils were 1.5 for impairment Class 0, 2.2 for Class 1, 1.7 for Class 2, 6.8 for Class 3, and 16.3 for Class 4. No relationship was found between the levels of exhaled NO and the functional parameters as well as the impairment class. NO levels in ppb were 21 for impairment Class 0, 30 for Class 1, 22 for Class 2, 26 for Class 3, and 49 for Class 4. This study also provides objective evidence that airway inflammation, as indicated by induced sputum, corroborates the rating of respiratory impairment in patients with asthma.
引用
收藏
页码:1434 / 1438
页数:5
相关论文
共 28 条
[1]   IDENTIFICATION OF ACTIVATED LYMPHOCYTES-T AND EOSINOPHILS IN BRONCHIAL BIOPSIES IN STABLE ATOPIC ASTHMA [J].
AZZAWI, M ;
BRADLEY, B ;
JEFFERY, PK ;
FREW, AJ ;
WARDLAW, AJ ;
KNOWLES, G ;
ASSOUFI, B ;
COLLINS, JV ;
DURHAM, S ;
KAY, AB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (06) :1407-1413
[2]   NO or no NO in asthma? [J].
Barnes, PJ .
THORAX, 1996, 51 (02) :218-220
[3]   IDENTIFICATION OF LYMPHOCYTES-T, MACROPHAGES, AND ACTIVATED EOSINOPHILS IN THE BRONCHIAL-MUCOSA IN INTRINSIC ASTHMA - RELATIONSHIP TO SYMPTOMS AND BRONCHIAL RESPONSIVENESS [J].
BENTLEY, AM ;
MENZ, G ;
STORZ, C ;
ROBINSON, DS ;
BRADLEY, B ;
JEFFERY, PK ;
DURHAM, SR ;
KAY, AB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (02) :500-506
[4]   AIRWAY INFLAMMATION AFTER REMOVAL FROM THE CAUSAL AGENT IN OCCUPATIONAL ASTHMA DUE TO HIGH AND LOW-MOLECULAR-WEIGHT AGENTS [J].
BOULET, LP ;
BOUTET, M ;
LAVIOLETTE, M ;
DUGAS, M ;
MILOT, J ;
LEBLANC, C ;
PAQUETTE, L ;
COTE, J ;
CARTIER, A ;
MALO, JL .
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (09) :1567-1575
[5]  
Chan-Yeung Moira, 1993, P299
[6]  
CHANYEUNG M, 1993, AM REV RESPIR DIS, V147, P1056
[7]  
CHANYEUNG M, 1973, AM REV RESPIR DIS, V108, P1094
[8]  
CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659
[9]  
CRIMI E, 1997, AM J RESP CRIT CARE, V157, P4
[10]   Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma [J].
Deykin, A ;
Halpern, O ;
Massaro, AF ;
Drazen, JM ;
Israel, E .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (03) :769-775